Using protein structures generated by the AI software AlphaFold, researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds. Over ...

AI drug discovery startup Aureka Biotechnologies closed a $100 million Series B on August 10, 2026, backed by an open-source ...

The research was conducted by EMBL's European Bioinformatics Institute (EMBL-EBI), the Institute of Molecular Systems Biology ETH Zurich, and the School of Biological Sciences Seoul National ...

Google DeepMind has unexpectedly released the source code and model weights of AlphaFold 3 for academic use, marking a significant advance that could accelerate scientific discovery and drug ...

Posts from this topic will be added to your daily email digest and your homepage feed. AlphaFold 3 uses the same method as AI image generators to predict how different molecules fit together.

AlphaFold 3 can predict how DNA, RNA, and other molecules interact, further cementing its leading role in drug discovery and research. Who will benefit? Google DeepMind has released an improved ...

The award-winning team behind Google DeepMind's AlphaFold program is no more, according to Financial Times. Google has reassigned most of the team's key members and the original a ...

Google DeepMind has dismantled the team behind AlphaFold, its Nobel Prize-winning AI system for predicting protein structures, as the ...

Pharmaceutical researchers in the United Kingdom are using the artificial intelligence tool AlphaFold to develop new psychedelic drugs, according to research released last month. The research, which ...

Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming. One promising new ...